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Summary 
Thymic T  cell anergy, as manifested by thymocyte proliferative unresponsiveness to antigens 
expressed in  the  thymic environment, is  commonly believed to  mediate  the acquisition  of 
immunological self-tolerance. However, we previously found that thymic T cell anergy may lead 
to the breakdown of tolerance and predispose to autoimmunity in nonobese diabetic (NOD) 
mice. Here, we show that NOD thymic T cell anergy, as revealed  by proliferative unresponsiveness 
in vitro after stimulation through the T cell receptor (TCR), is associated with defective TCR- 
mediated signal transduction along the PKC/p21~'qp42m~p  k pathway of T cell activation.  PKC 
activity is  reduced in  NOD  thymocytes.  Activation  of p21 ~'* is  deficient in  quiescent  and 
stimulated  NOD T  cells, and this  is correlated with a significant reduction in the tyrosine 
phosphorylation of p42maP  k, a serine/threonine kinase active downstream of p21 ~'s. Treatment 
of NOD T cells with a phorbol ester not only enhances their p21 r~s activity and p42m~p  k tyrosine 
phosphorylation but  also restores  their proliferative responsiveness. Since p42m'p  k activity is 
required for progression through to S phase of the cell cycle, our data suggest that reduced tyrosine 
phosphorylation of p42m'v  k in stimulated NOD T cells may abrogate its activity and elicit the 
proliferative unresponsiveness of these cells. 
F 
unctional inactivation or anergy of a T cell is manifested 
by a long-lasting proliferative unresponsiveness, and may 
occur as a consequence of an interaction between an Ag or 
mitogen with the CD3-TCR complex in the absence of a 
second non-Ag-specific costimulator signal provided by an 
APC (1). T cell anergy in the thymus and/or periphery gener- 
ally results in immunological self-tolerance  (2-4). In contrast, 
we have found that beginning at the time of insulitis (7 wk 
of age), mature CD4 *  8- and CD4- 8 + thymic T cells from 
prediabetic NOD mice are anergic as assessed  by stimulation 
of proliferation in vitro after TCR cross-linking with either 
an anti-TCR mAb, anti-CD3 mAb, or Con A. This anergy 
is not due to the inability of thymic APCs to provide costimu- 
lation (5, 6, and Rapoport, M., A. Jaramillo, D. Zipris, A. 
Lazarus, D. Serreze, E. Leiter, P. Cyopick, and T. Delovitch, 
manuscript submitted for publication), but rather arises pre- 
dominantly from the inability of these NOD thymic T cells 
to be stimulated to produce sufficient amounts of IL-4 to sup- 
port their proliferation (6, and Rapoport, M., et al., manu- 
script submitted for publication). IL-4 completely reverses  this 
thymic T cell anergy in vitro and when administered in vivo, 
prevents the onset of diabetes in NOD mice (Rapoport, M. 
et al., manuscript submitted for publication).  These studies 
raise the possibility that thymic T cell anergy might influence 
susceptibility to diabetes in NOD mice. Elucidation of the 
biochemical mechanisms of this NOD thymic T cell anergy 
may further unravel the basis of the polygenic control of sus- 
ceptibility  to type I diabetes. 
In many types of cells, interactions  between membrane 
receptors and a variety of growth factors leads to the activa- 
tion of the protooncogene p21 ras and subsequent cell proli- 
feration (7-10). Stimulation  of T cell proliferation through 
the TCR very rapidly activates p21 ~as by converting  its in- 
active GDP-bound form to its active GTP-bound form (11). 
Previously, we observed that stimulation of NOD thymic 
T cells with phorbol esters (e.g,, phorbol 12-myristate 13- 
acetate, PMA) restores their proliferative responsiveness  upon 
cross-linking of their TCR (5). Since phorbol ester-induced 
activation  of protein kinase C  (PKC) augments p21 ras ac- 
tivity in T cells (11), we examined whether deficient activa- 
tion  of the p21 r~s pathway mediates  the proliferative un- 
responsiveness of NOD thymic T cells. This report provides 
evidence in support of this notion by demonstrating deficient 
p21 ~  activation  and  p42m~v  k  tyrosine phosphorylation in 
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by treatment with PMA. 
Materials  and Methods 
Reagents and mAbs.  Ascites  containing the H57-597 anti-TCR- 
ct//3 mAb (12) was generously provided  by Dr. R. Kubo (National 
Jewish Centre for Immunology and Respiratory Medicine, Denver, 
CO). The 145-2Cll anti-CD3e mAb (13) was kindly supplied by 
Dr. J. Bluestone (University of Chicago, Chicago, IL). The Py-72 
anti-phosphotyrosine mAb (14) was kindly provided by Dr. B. M. 
Sefton (Salk Institute, San Diego, CA). Murine rib2 (15) was a 
kind gift from Dr. G. B. Mills (Toronto General  Hospital, Toronto, 
Ontario,  Canada). Recombinant human p21  r  and the rabbit 
anti-GTPase activating  protein (GAP) polyclonal  antibody (16) were 
kindly provided  by Dr. M. F. Moran (C. H. Best Institute, Toronto, 
Ontario, Canada). 
T Cell Isolation and Activation.  Prediabetic male and female  in- 
bred 8-12-wk-old NOD/Dr mice were used. Insulitis  in these mice 
occurs at 7 wk of age, and diabetes incidence  is 50-60% in females 
and 10% in males  by 24 wk of age. Age- and sex-matched  BALB/cJ 
mice were used as controls. Thymic T ceils and purified splenic 
T ceils were isolated as described (Rapoport, M. et al., manuscript 
submitted for publication). Splenic  T cells  consisted  of >95% T cells 
as estimated by FACS  |  analysis  (Becton Dickinson & Co., Moun- 
tain View, CA) with the anti-CD3 mAb. Thymic T cell  blasts were 
generated by stimulation of thymocytes with Con A (2.5/zg/ml; 
Sigma Immunochemicals, St. Louis, MO) for 48 h in RPMI 1640 
medium supplemented  with 10% FCS, antibiotics  and 50/~M 2-ME 
(complete RPMI). After washing three times, cells  were maintained 
in exponential growth for 72 h in this medium supplemented  with 
100 U/ml rlL-2. Cells were deprived of Ib2 and rested for 24 h 
before use in various functional assays. Alternatively, T cells were 
activated by PMA (100 ng/ml; Sigma Immunochemicals) before 
assay. 
p21'~ Assay.  Cells  (5  x  107/ml) were permeabilized by addi- 
tion of  0.4 U/ml of streptolysin  O (Wellcome  Diagnostics, Green- 
ville, NC) and labeled with ct-[3zP]GTP (5/~Ci; 3,000 Ci/mmol), 
as described (11). The CHELATE program (17) was used to pre- 
dict  the  concentrations of CaC12 and MgC12 required to  give 
100 nM and 5 mM free Ca  2  + and free Mg  2+ , respectively, at pH 
7.2 and 37~  After stimulation, cells  were lysed  in ice-cold 50 mM 
Hepes buffer, pH 7.4, containing 1% NP-40, 1 mM EGTA, 150 
mM NaC1, 5 mM MgC12, 1 mM PMSF, 10 /zg/ml leupeptin, 
10/~g/ml aprotinin, 10/zg/ml soybean  trypsin inhibitor, 0.5% deox- 
ycholate, and 0.05% SDS. Lysates  were precleared for 2 h at 4~ 
with goat anti-rat IgG coupled to agarose (0.5 ml, 50% solution; 
Sigma Immunochemicals).  Immunoprecipitations (60 min at 4~ 
were performed in duplicate using 30/~g/ml of either the Y13-259 
rat anti-p21  ~-n-'~ mAb (Oncogene Science Inc,, Manhasset, NY) 
or normal rat IgG (Jackson  Immunoresearch  Laboratories,  Inc., West 
Grove, PA), and then goat anti-rat IgG coupled to agarose. After 
washing immunoprecipitates 8 x, nucleotides were eluted during 
an incubation for 20 min at 68~  and separated on polyethylene- 
imine-cellulose thin layer  chromatography phtes developed  in I M 
KH2PO4, pH 3.4 (11). Plates were autoradiograplied, and deter- 
mination of the ras-bound GTP/GTP plus GDP ratio was evalu- 
ated by. B-scintillation counting. 
ras.GAP Assay.  Cells  were disrupted in lysis  buffer B (20 mM 
Tris-HC1, pH 7.5, 1% Triton X-100, 0.5% DTT, 100 mM NaC1, 
1 mM MgC12, 50/~g/ml leupeptin, 10/~g/ml aprotinin, 0.5 mM 
PMSF, and 0.2 mM Na3VO~). Aliquots of lysates were immuno- 
precipitated with either a polyclonal rabbit anti-ras.GAP Ab or a 
control preimmune rabbit serum and protein A-Sepharose (Phar- 
macia LKB Biotechnology Inc., Piscataway, NJ). GAP activity in 
these immunoprecipitates was assayed,  as described (16). GAP ac- 
tivity in nonactivated  T cells (calculated  as p21~-bound basal cpm) 
-  (p21~-bound cpm in nonactivated  cells) was taken to represent 
maximal (100%) GAP activity. The relative GAP activity in acti- 
vated T  ceils was calculated as follows: 100% x  [(p21"s-bound 
basal cpm)-  (p21ra%ound cpm in activated cells)/(p21r~%ound 
basal cpm)-  (p21~-bound cpm in nonactivated cells)]. 
PKC Assay.  Thymocytes (2  x  107/ml) were washed in PBS 
and lysed by sonication. Intact cells were removed by low speed 
centrifugation, and the lysates  were analyzed  for their PKC activity 
measuring 32p incorporation into histone H1, as described (18). 
Western Blots.  Quiescent or activated T cells (107) were resus- 
pended in suspension buffer (150 ram NaC1, 500 #M Na3VO4, 
50/~M ZnC12, 2 mM EDTA, 2 mM PMSF, 50 mM Hepes, pH 
7.2), and then boiled for 10 rain in SDS sample buffer (16). Pro- 
teins were resolved  by SDS-PAGE, transferred  to nitrocellulose  mem- 
branes (Schleicher  & Schuell, Inc., Keene,  NH) and immunoblotted 
successively with  the  Py-72 antiphosphotyrosine mouse  mAb 
(1 #g/ml) or a control mouse mAb (1  /~g/ml) for 4 h,  rabbit 
anti-mouse IgG (2/zg/ml, Jackson Immunoresearch  Laboratories, 
Inc.) for 1 h and nSI-labded protein A (1 /zCi/ml,  Amersham 
Corp., Arlington Heights, IL) for 1 h. Membranes  were then dried 
and autoradiographed  for 24 h. For detection of p42  mapk, GAP, and 
PKC, cell samples were processed and immunoblotted with a poly- 
clonal rabbit anti-p42maP  k antibody (1 /~g/ml, Upstate Biotech- 
nology, Inc., Lake Placid, NY), polyclonal rabbit anti-GAP anti- 
serum (1:500 dilution), and a pan-reactive  rabbit anti-PKC antibody 
(2/~g/ml, UBI), respectively,  or a control rabbit preimmune serum 
(1:500 dilution). 
Results  and  Discussion 
The  ability of TCIL cross-linking  to  activate  p21 ras  in 
thymocytes from 8-wk-old BALB/c (H-2  d) and prediabetic 
NOD (H-2g  7) mice that display high and low proliferative 
responsiveness (5), respectively, was assessed. Con A induced 
a  four-  to  fivefold  increase  in  p21 r~s  activity in  activated 
BALB/c thymocytes, whereas it failed to induce p21 ~a' acti- 
vation in NOD thymocytes (Fig.  1 A). Western blots ob- 
tained using the pan-reactive Y13-259 anti-ras mAb showed 
no significant difference in the amounts of p21 ra~ present in 
BALB/c and NOD thymocytes (Lazarus, A. H., unpublished 
data). To examine whether NOD thymic T  cell blasts are 
also characterized by decreased p21  r~ activity, we determined 
the p21TM activity in NOD and BALB/c Con A  activated 
thymic T  cell blasts.  The relative  amount of GTP-bound 
p21 r~ in stimulated rested NOD T call blasts was consider- 
ably lower than that observed in similarly treated control 
BALB/c T  cell blasts (Fig.  1 B).  Con A  stimulates a two- 
to threefold increase  in p21 ~' activity in BALB/c but not 
NOD spleen T  cells (Fig.  1 C). Thus, deficient p21 ~  acti- 
vation is an inherent signaling defect that is expressed after 
stimulation of quiescent NOD thymocytes as well as NOD 
thymic and peripheral T  cell blasts. 
Activation of p21 "~' in T cells stimulated via the TCR is 
regulated by an inhibition of p21 ~' GTPase activity (11, 19, 
20). To examine whether the relatively low amount of GTP- 
bound p21 r~s observed  in stimulated NOD  T  cells results 
from a decrease in the activity of the associated GTPase ac- 
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cells. (A) NOD (lanes 1-3) and BALB/c (lanes 4-6) quiescent thymocytes 
were isolated and incubated in the absence  (lanes 2 and 5) or presence  (lanes 
3 and 6) of Con A (2.5/~g/ml)  for 15 min at 37~  in complete RPMI 
medium. The p21TM activities of these cells were then analyzed as indi- 
cated. Samples  were immunoprecipitated with either the Y13-259 rat anti- 
v-H p21  ~s mAb (lanes 2, 3, 5, and 6) or normal rat IgG (lanes 1 and 4). 
(B) NOD (lanes 1-3) and BALB/c (lanes 4-6) thymic T cell blasts were 
generated by stimulation of thymocytes with Con A for 48 h, maintained 
in exponential growth for 72 h in the presence of rlL-2 (100 U/ml), and 
then deprived of II,-2 for 24 h before assay of p21  r~s activity. In this ex- 
periment,  the relative amount of GTP-bound p21  ~'* was greater in un- 
stimulated NOD thymocytes  (lane  2) than in unstimulated BALB/c thymo- 
cytes (lane 5). In general, this was not the case as is evident in Fig. 4 A. 
(C) NOD (lanes I-3) and BALB/c (lanes 4-6) splenic T cells were acti- 
vated by Con A and their p21TM activities analyzed as in (A) above. 
tivating protein  (ras.GAP, Mr  120,000)  (11,  21,  22),  we as- 
sayed  both  the  relative  activities  and  amounts  of ras.GAP 
present in stimulated and control unstimulated  thymocytes. 
The  level of ras.GAP  activity was  equivalent  in  stimulated 
NOD  and BALB/c thymocytes (Fig. 2 A). Basal ras.GAP ac- 
tivity was also comparable in both unstimulated  NOD  and 
BALB/c thymocytes.  Comparable  amouts  of p120  ras.GAP 
were present  in  NOD  and  BALB/c thymocytes (Fig.  2 B). 
Thus,  the  relative  activities  and  amounts  of ras.GAP  were 
equivalent  in activated NOD  and BALB/c thymocytes, and 
a decrease in activity or amount of ras.GAP does not account 
for  reduced  GTP-bound  p2Y  ~' in  activated  NOD  thymo- 
cytes. Deficient activation of p21 r~, in NOD  T  cells is there- 
fore regulated by either another GAP protein, e.g.,  the NF1 
GAP  protein  (23,  24)  or  a  guanine  nucleotide  releasing 
factor(s)  (11,  19,  20). 
Stimulation  of T  cells via the TCR  or by phorbol esters 
(e.g.,  PMA)  results  not  only  in  p21 r~' activation  but  also 
tyrosine phosphorylation and activation of a family of serine/ 
Figure  2.  Relative  activity and quantity of ras.GAP protein is normal 
in NOD thymocytes. (A) Quiescent thymocytes from NOD and BALB/c 
mice were incubated for 15 min at 37~  in complete RPMI in the absence 
(open bars)  or presence (solid  bars)  of Con A (2.5 #g/ml). ras.GAP  was then 
immunoprecipitated  and  tested for its  enzymatic activity. The p21  .... 
bound basal cpm value was 93,000. The p21r~s-bound cpm values in acti- 
vated NOD and BALB/c thymocytes  were about 68,000 and 59,000, respec- 
tively. The p21r~'-bound cpm values for nonactivated NOD and BALB/c 
thymocytes were about 55,000 and 44,000, respectively. The values for 
percent inhibition of GAP activity in NOD and BALB/c T cells are shown. 
(B) Western blots of cell lysates from NOD (lanes I and 2) and BALB/c 
thymocytes  (lanes  3 and 4). Proteins derived  from thymic NOD and BALB/c 
T cells were quantitated for the amount of ras.GAP using an anti-GAP 
antiserum (lanes 2 and 4) or a control rabbit preimmune serum (lanes I 
and 3),  as indicated. 
threonine  protein kinases known  as MAP kinases (MAPK) 
(25).  Two forms of MAPK  of Mr 42,000  (termed p42m~v  k) 
and 44,000  (termed p44m~P  k) exist. These MAPK participate 
in  the control  of the G0-G1 transition  of the cell cycle and 
the passage of cells through  either meiosis or mitosis  (26). 
Active GTP-bound p21  TM  is an upstream effector of MAPK 
activation by various growth factors in many cell types (26). 
However, a direct link between p21  TM  and MAPK activities 
has not yet been demonstrated in T cells. If such a link exists, 
reduced p21  TM  activity should be associated with diminished 
MAPK tyrosine phosphorylation in stimulated NOD  thymo- 
cytes,  since tyrosine phosphorylation  of MAPK  is required 
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creased in activated NOD thymocytes. (.4) NOD (N; lanes 
2, 4, 6, and 8) and BALB/c (B; lanes 1,3, 5, and 7) quies- 
cent thymocytes (107) (lanes 1-4) or rested thymic T cell 
blasts (lanes 5-8) were each activated for 15 min at 37~ 
by the 145-2Cll anti-CD3 mAb (12.5%  [vol/vol] solu- 
tion of hybridoma supernatant).  Cell samples were then 
analyzed by immunoblotting using the Py-72 mouse an- 
tiphosphotyrosine mAb. (B) Western blots in (.4) were 
stripped of bound antibody and reimmunoblotted with 
a polyclonal rabbit anti-p42r~p  k affinity-purified antibody. 
When these blots were overlayed on their respective an- 
tiphosphotyrosine blots, the position of p42m~p  k was su- 
perimposable on the 42-kD tyrosine phosphorylated band 
in (.4). 
Figure  4.  Effect of PMA on NOD T  cell activation. (.4) PMA acti- 
vates p21  r~s in NOD T cells. Cells were either unstimulated (lanes 1, 4, 
7, and 10) or stimulated for 15 min with PMA (100 ng/ml) (lanes 2, 3, 
5, 6,  8,  9,  11, and 12). The Y13-259 anti-p21TM  mAb was used for the 
immunoprecipitation of samples in lanes 3, 6, 9, and 12, and normal rat 
IgG was used to treat samples in lanes I, 2, 4, 5, 7, 8, I0, and 11. Thin 
layer chromatograms of p21~as-bound nucleoddes eluted from unstimu- 
lated and stimulated NOD thymocytes (lanes 1-3) and splenic T cells (lanes 
4-6) and from unstimulated and stimulated BALB/c  thymocytes (lanes 
7-9) and splenic T cells (lanes I0-I2)  are displayed. (B) PMA stimulates 
tyrosine phosphorylation  of p42m~# and p44m~p  k in NOD T cells. BALB/c 
(lanes 1 and 3) and NOD (lanes 2 and 4) quiescent thymocytes were either 
not activated  (lanes 1 and 2) or activated  (lanes 3 and 4) by PMA for 5 
min at 37~  lysed, and analyzed by Western blot analysis with the Py-72 
antiphosphotyrosine mAb, as indicated. 
for its activity (25). Anti-CD3 induced substantially less tyro- 
sine phosphorylation of a 42-kD protein in NOD  thymo- 
cytes in comparison to BALB/c thymocytes (Fig.  3 A).  A 
lesser increase in the induced tyrosine phosphorylation of a 
44-45-kD protein was also observed in activated  NOD vs. 
BALB/c thymocytes. Similar results were obtained with NOD 
and BALB/c restimulated thymic T cell blasts. Reactivity with 
a polyclonal rabbit anti-MAPK antibody identified the 42- 
and 44-45-kD  proteins to be p42map  k and p44m~P  k, respec- 
tively, and to be present in similar amount in activated NOD 
and BALB/c thymocytes (Fig. 3 B). These findings suggest 
that a defect in TCR,-mediated activation of p21TM may re- 
sult in reduced tyrosine phosphorylation and activation of 
p42m~P  k and p44m~P  k, which subsequently may inhibit the 
progression through cell cycle and proliferation of NOD 
thymocytes. 
Direct activation of PKC by PMA in combination with 
either the calcium ionophore ionomycin or Con A corrects 
the proliferative defect of NOD thymocytes (5). PMA-induced 
activation of PKC also augments p21TM activity in T  cells 
(11).  We  therefore examined whether  activation of PKC 
by PMA is able  to overcome deficient  p21TM activation in 
stimulated NOD thymic T cells. PMA elicited similar levels 
of p21  r~s activation in NOD  and BALB/c thymocytes and 
splenic  T  cells  (Fig.  4  A).  Tyrosine  phosphorylation of 
p42m~P  k and p44m~P  ~ is also comparable in both NOD  and 
BALB/c PMA stimulated quiescent thymocytes (Fig. 4 B). 
Thus, PMA stimulation of PKC results in normal p21TM  ac- 
tivation and p42m~P  k and p44map  k tyrosine phosphorylation. 
Two distinct signaling pathways activated through the TCR, 
a PKC-dependent and a non-PKC-dependent pathway, regu- 
late p21TM  activity in T  cells (19, 20).  Our previous obser- 
vations (5, and Rapoport, M. et al.,  manuscript submitted 
for publication) that the basal levels of expression of many 
cell surface molecules, including the TCR, CD3, CD4, CDS, 
and the Ib2R are comparable in NOD and BALB/c thymic 
T  cells, raised the possibility that basal levels of activity of 
certain signal transduction intermediates, such as PKC, may 
differ between T  cells from these two mouse strains.  PKC 
1224  Deficient Pathway of p21  r~ Activation in Anergic NOD  T  Cells Figure 5.  Basal  PKC activity  is reduced  in NOD thymocytes.  (A) Specific 
PKC activity  was quantitated as described  in the text. (B) The results shown 
represent the mean values + SEM obtained from densitometric scans of 
samples from nine NOD mice. (C) Western  blots of  cell  lysates  from  NOD 
(lanes I and 2) and BALB/c  thymocytes  (lanes 3 and 4) probed  with either 
2 #g/m1 of a pan-reactive rabbit anti-PKC antibody (lanes 2 and 4) or 
normal rabbit IgG (lanes I  and 3) and a2SI-protein A. 
activation  is  required  for  the  PKC-dependent  pathway  of 
p21  TM  activation (11). To examine whether the low p21  r~S ac- 
tivity in NOD T  cells may be linked to decreased levels of 
PKC activity, we measured the basal levels of PKC enzymatic 
activity in vitro in NOD and BALB/c thymic T cell lysates. 
The basal activity of PKC in quiescent  NOD  thymocytes 
was reduced about twofold compared with that observed in 
control BALB/c thymocytes (Figs.  5, A  and B). Comparable 
amounts of PKC protein were detected by a polyclonal rabbit 
anti-mouse PKC antibody that recognizes all PKC isoforms 
in Western blots of NOD and BALB/c thymocytes (Fig. 5 C). 
Conceivably, the deficient basal PKC activity in NOD thymic 
T cells may give rise via the PKC-dependent pathway to de- 
creased p21TM activity in  these T  cells. 
Thus, NOD thymic and peripheral T  cell anergy may re- 
sult from a defect(s) along the PKC/p21=s/p42mav k pathway 
of T  cell  activation.  This  possibility is  supported  by our 
findings presented here that:  (a) PKC activity is reduced in 
NOD thymocytes; (b) p21TM activation is deficient in quies- 
cent and stimulated NOD T cells; (c) a direct link exists be- 
tween p21 r's and MAPK activation  in T  cells;  (d) the level 
of tyrosine phosphorylation of p42m~P  k is diminished  in ac- 
tivated NOD T  cells;  (e) PMA corrects the proliferative de- 
fect of NOD T  cells;  and ~  PMA enhances both p21TM ac- 
tivity and MAPK tyrosine phosphorylation in activated NOD 
T cells. Since MAPK activity is required for gene activation, 
progression through  the cell cycle and cell proliferation,  re- 
duced  tyrosine  phosphorylation  of p42m~v  k in  stimulated 
NOD T cells likely abrogates its activity and elicits the prolifer- 
ative unresponsiveness  of these cells. 
Peripheral T cell anergy has been documented both in NOD 
mice (5, 27, 28) and in prediabetic patients (29), and in the 
latter case has been implicated as an indicator of progression 
to  overt  disease.  Our  observation  that  p21 r's  activation  is 
deficient in stimulated NOD peripheral T cells therefore raises 
the possibility that  analysis  of p21 =' activity in human pe- 
ripheral blood T  cells may be used to detect diabetes onset 
in prediabetic individuals at high risk.  It also remains to be 
determined whether our findings of decreased p21  r'~ activity 
are restricted to anergic prediabetic NOD T cells or can also 
be applied to anergic T  cells in other autoimmune diseases. 
The latter scenario would provide additional support for the 
possibility raised herein that an important  association exists 
between a defect(s) in TCR-linked  signal transduction  and 
susceptibility to T  cell-mediated  autoimmune  disease. 
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